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We compared pregnancy outcomes following intracytoplasmic sperm injection for the treatment of male
infertility according to the type of azoospermia. First, we analyzed our data from 370 couples who underwent
intracytoplasmic sperm injection using sperm from men with obstructive azoospermia and nonobstructive
azoospermia, and the outcomes were compared to a group of 465 non-azoospermic infertile males. Then, we
performed a systematic review of the published data on pregnancy and neonatal outcomes of children born
after sperm injection using sperm from men with obstructive and nonobstructive azoospermia. Live birth rates
were significantly lower in the nonobstructive azoospermia group (21.4%) compared with the obstructive
azoospermia (37.5%) and ejaculated sperm (32.3%) groups. A total of 326 live births resulted in 427 babies
born. Differences were not observed between the groups in gestational age, preterm birth, birth weight and
low birth weight, although we noted a tendency towards poorer neonatal outcomes in the azoospermia
categories. The overall perinatal death and malformation rates were 2.8% and 1.6%, respectively, and the
results did not differ between the groups. We identified 20 published studies that directly compared pregnancy
outcomes between obstructive azoospermia and nonobstructive azoospermia. Most of these studies were not
designed to detect differences in live birth rates and had lower power to detect differences in less frequent
outcomes, and the reporting of neonatal outcomes was unusual. The included studies reported either a
decrease or no difference in pregnancy outcomes with intracytoplasmic sperm injection in cases of
nonobstructive azoospermia and obstructive azoospermia. In general, no major differences were noted in
short-term neonatal outcomes and congenital malformation rates between children from fathers with
nonobstructive azoospermia and obstructive azoospermia.
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& INTRODUCTION
Worldwide, an estimated 9% of couples meet the
definition of infertility, with 50% to 60% of these couples
seeking care (1). From a global perspective, these figures
indicate that approximately 140 million individuals at
reproductive age are unintentionally childless or have
undergone treatment to reproduce (2). With regards to the
male population, it has been estimated that 8% of men at
reproductive ages seek medical assistance for infertility-
related problems, and 1-10% of them have a condition that
affects their reproductive potential (3).
One of these conditions is azoospermia, defined as the
complete absence of spermatozoa in the ejaculate after
centrifugation, which occurs in 1-3% of the male population
and approximately 10% of infertile males (4). Despite being
associated with infertility, azoospermia does not necessarily
imply sterility because many azoospermic men maintain
sperm production at varying levels within the testes (5). In
fact, two distinct clinical presentations are usually seen in
men with azoospermia. In obstructive azoospermia (OA),
spermatogenesis is normal, but either a mechanical blockage
exists in the genital tract between the epididymis and the
ejaculatory duct or the vasa deferentia are absent. Causes of
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OA may be either acquired or congenital and include
vasectomy, failure of vasectomy reversal, post-infectious
diseases, surgical procedures in the scrotal, inguinal, pelvic
or abdominal regions, cystic fibrosis, congenital absence of
the vas deferens (CAVD), ejaculatory duct or prostatic cysts
and Young’s syndrome. Unlike OA, men presenting with
nonobstructive azoospermia (NOA) either lack or have
severely impaired spermatogenesis. NOA comprises a
spectrum of testicular histopathology resulting from various
causes that include genetic and congenital abnormalities,
infection, exposure to gonadotoxins, medications, varico-
cele, trauma, endocrine disorders, and idiopathic disorders
(5). In a group of 2,383 infertile men attending the tertiary
center for male reproduction of one of the authors (SE), 835
(35%) were identified as having azoospermia; approxi-
mately 36% of those cases resulted from obstruction in the
ductal system, whereas over 60% were associated with
testicular failure caused by different conditions (Table 1).
Although selected cases of OA may be surgically correct-
able, treatment options for most couples with azoospermia-
related infertility will ultimately include assisted reproduc-
tive techniques (ART), which is a broad term used to define
any procedure that involves handling of both sperm and
oocytes outside the body, such as in vitro fertilization (IVF)
and its variant, intracytoplasmic sperm injection (ICSI) (6). To
this end, several sperm retrieval methods have been
developed to collect epididymal and testicular sperm to be
used in conjunction with ART for men with azoospermia.
Briefly, either percutaneous (PESA) or microsurgical epidi-
dymal sperm aspiration (MESA) are used to retrieve sperm
from the epididymis in men with obstructive azoospermia,
and testicular sperm aspiration (TESA) or testicular sperm
extraction (TESE) are used to retrieve sperm from the testes
both in men with OA who fail PESA and those with NOA (7).
The clinical application of ART has increased significantly
over time. According to the International Committee for
Monitoring Assisted Reproductive Technology (ICMART),
an international non-profit organization that collects data on
ART and monitors approximately 2/3 of ART treatments
performed worldwide, the number of treatments has
steadily increased since its first report in 1998 (8,9). Along
the same trend, the number of babies born from such
treatments rose from 84,594 in 1998 to approximately
180,000 in 2003 (an increase of 103%). Similarly, the
proportion of total births resulting from ART increased
from 0.37% in 1996 to slightly more than 1% in 2009 in
industrialized countries such as the United States (10).
Intracytoplasmic sperm injection, which is mainly intended
to bypass severe male factor infertility, including azoosper-
mia, has become the most used form of ART treatment (8).
Although these treatments improve the chances that a
couple become parents, they also carry risks, including
multiple gestations and preterm delivery, which carries an
increased risk of short- and long-term post-natal complica-
tions. Nevertheless, there has been a large number of babies
born after ICSI in cases of severe male infertility, including
azoospermia, and concerns still exist regarding whether the
use of spermatozoa from such individuals might affect the
health of offspring (11).
The purpose of this study was to compare the pregnancy
results due to intracytoplasmic sperm injection and neonatal
outcomes of children born after ICSI using surgically-
retrieved sperm from men with obstructive and nonobstruc-
tive azoospermia with the results from non-azoospermic
infertile males treated with sperm injection. In addition, we
present a systematic review of published data comparing the
pregnancy outcomes after ICSI for the treatment of male
infertility due to obstructive and nonobstructive azoospermia
and the short- and long-term safety of such interventions.
& METHODS
Study Group
Consecutive ICSI cycles involving fresh embryo transfers
performed at Androfert from January 2004 to December
2010 were initially screened. A total of 471 ICSI cycles using
fresh surgically-extracted sperm from men with azoosper-
mia and 621 cycles using fresh ejaculated sperm from men
with male factor infertility were reviewed in detail and
included in the analysis. A complete male and female
workup was conducted in all couples before enrollment in
our ART program to both determine the cause of infertility
and the treatment strategy as previously described (5).
Semen analyses were performed on at least two different
occasions according to the World Health Organization
criteria (12). Azoospermic individuals were seen by the
Table 1 - Distribution of Diagnostic Categories and Frequency of Azoospermia in a Group of Infertile Men Attending a
Tertiary Center for Male Reproduction.
Category Number and Absolute Frequencies; N (%)
Men Presenting with Azoospermia;
Number and Relative Frequencies, N (%)
Varicocele 629 (26.4) 32 (5.1)
Post-infectious1 161 (6.9) 57 (35.4)
Endocrine 54 (2.3) 26 (48.1)
Ejaculatory dysfunction 28 (1.1) NA
Systemic disease 11 (0.4) 2 (18.1)
Idiopathic|| 645 (27.1) 178 (27.6)
Immunologic 54 (2.2) None
Obstruction" 259 (10.9) 244 (94.2)
Cancer 11 (0.4) 4 (36.3)
Cryptorchidism 342 (14.4) 174 (50.8)
Genetic{ 189 (7.9) 118 (62.4)
TOTAL 2,383 (100.0) 835 (35.0)
Obstructive Azoospermia; N (%) 302 (36.1)
Nonobstructive Azoospermia; N (%) 507 (60.7)
1 include orchitis and sexually transmitted diseases; ||include testicular failure and idiopathic obstruction; " include vasectomy and ejaculatory duct
obstruction; {include congenital absence of vas deferens, Yq microdeletion and Klinefelter syndrome.
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urological team to diagnose whether the azoospermia was
obstructive or nonobstructive. Of the 370 azoospermic men,
182 and 188 had OA and NOA, respectively. The distinction
between obstructive and nonobstructive azoospermia took into
account the history, physical examination, endocrine analysis,
and genetic testing as appropriate (5). In addition, diagnostic
sperm retrieval and testis biopsy for histopathology analysis
were conducted in selected cases. The type of azoospermia was
further confirmed by testicular histopathology in all testicular
sperm retrievals performed at the time of sperm injections.
Indications for ICSI were in accordance with the guidelines of
the II Brazilian Consensus of Male Infertility (13).
Laboratory and clinical protocols remained practically
unchanged during these time periods. Ovarian stimulation,
oocyte and sperm retrieval, sperm processing, and IVF were
conducted as previously reported (14-17). Briefly, percuta-
neous epididymal (PESA) and/or testicular sperm aspira-
tion (TESA) were performed in cases of obstructive
azoospermia, and microsurgical testicular sperm extraction
(micro-TESE) or testicular sperm aspiration (TESA) was
used for sperm collection in nonobstructive azoospermia.
Ejaculated spermatozoa were processed by discontinuous
colloidal gradient. Oocytes were retrieved after ovarian
stimulation with gonadotropins in association with either
pituitary down-regulation with gonadotropin-releasing
hormone (GnRH) agonists or luteinizing hormone (LH)
surge suppression with GnRH antagonists. The cumulus-
corona-oocytes complexes were stripped, classified accord-
ing to nuclear maturity, and maintained in culture until
sperm microinjection. Sperm injections were conducted
under 4006 magnification using epididymal or testicular
sperm in OA, testicular sperm in NOA and ejaculated sperm
in non-azoospermic cases. The injected oocytes were trans-
ferred to a closed culture system and incubated for 16-
18 hours at 37 C˚ and 5.5% CO2 until fertilization was
confirmed. Fertilized oocytes were maintained in culture,
and embryo quality was scored daily according to the criteria
described by Veeck for cleaving embryos (18) and by Gardner
for blastocysts (19). The embryos were classified as top
quality when they had 3-4 and 7-8 symmetrical blastomeres
on the second and third days of culture, respectively, with no
multinucleation, 0-20% of the perivitelline space occupied
with fragments, and exhibited no abnormalities in the zona
pellucida. Embryos kept in extended culture were considered
top quality upon exhibiting full blastocyst formation and
onwards. Selected embryos were transferred to the uterine
cavity on the third or fifth day of embryo culture. Luteal
support with a once-daily transvaginal application of
progesterone gel was initiated in the day of oocyte retrieval
and continued up to the 12th gestational week. Oocyte and
sperm retrieval, micromanipulation of gametes, embryo
culture, and the transfer of embryos to the uterine cavity
were conducted in clean room environments (20).
Pregnancy was first detected using quantitative serum
beta-hCG testing and further confirmed clinically by
observing the presence of gestational sac on the seventh-
week ultrasound scan. In our program, clinical and
laboratory ART data are systematically and continually
entered into a database, and pregnancy follow-up is
conducted by telephone interviews on a monthly basis.
With confirmation of live birth, follow-ups continue with
the registration of gestational ages, birth weights, neonatal
disorders, and eventual malformations for a period of 30
days post-delivery. Pregnancy outcomes of all ART cycles
are annually reported to the Latin America ART Registry
(REDLARA). Signed informed consent was obtained from
patients to use both clinical and laboratory data for analysis
with guarantees of confidentiality.
For the statistical analysis, sperm injection cycles were
grouped according to the source of sperm used for ICSI, i.e.,
ejaculated or surgically-retrieved. In ICSI cycles with non-
ejaculated sperm, a distinction was made between OA and
NOA. The main pregnancy outcomes analyzed were clinical
pregnancy, ectopic pregnancy, miscarriage, live birth, and
the perinatal outcomes of babies born (parity, weight and
gestational age at the time of delivery, mortality and birth
defects). The qualitative variables were expressed as both
absolute (n) and relative (%) frequencies. The relationship
between the variables among groups was evaluated by the
Chi-square test and Fisher’s exact test as appropriate. The
quantitative variables were expressed as means and standard
deviations. An analysis of variance for one factor (one-way
ANOVA) was used to compare these variables when there
was a normal distribution, and differences were analyzed by
the Tukey multiple comparisons test. For the variables
without normal distribution, comparisons were performed
with the Kruskal–Wallis test, and the differences were
compared using the Dunn multiple comparisons test. A p-
value below 0.05 was considered significant. All analyzes
were processed using SPSSH, version 13.0 (SPSS Inc., Chicago,
IL, USA). Multiple pregnancies were considered as a single
event, and when one gestation produced one live birth and
one abortion, the result was registered as a live birth.
Systematic Review
The review was structured around one key question
involving short-term (including clinical pregnancy, sponta-
neous abortion, ectopic pregnancy, live birth and multiple
pregnancy) and long-term (preterm delivery, low birth
weight, neonatal and infant complications and longer-term
physical and developmental problems) pregnancy outcomes
for the fetus/child following sperm injections using fresh
surgically-retrieved sperm from men with OA and NOA.
Specifically, we intended to investigate if the pregnancy
outcomes after ICSI differ according to the classification of
azoospermia as obstructive or nonobstructive.
We searched Pubmed, Scielo and Open J-gate for English-,
Portuguese-, or Spanish-language studies published from
January 1995 through March 2012. The search was supple-
mented by a hand search of reviews published by the
Cochrane Library.
The search strategy used the National Library of Medicine’s
Medical Subject Headings (MeSH) keyword nomenclature. The
keywords were ‘‘reproductive techniques, assisted;’’ ‘‘infertility,
male;’’ ‘‘sperm injections, intracytoplasmic;’’ and ‘‘pregnancy’’
or ‘‘child.’’ Case reports and reviews were excluded. Articles
were also excluded if the type of azoospermia (obstructive or
nonobstructive) was not clearly stated or if only one azoos-
permia category was studied, regardless of whether or not a
control group of sperm injections using ejaculated sperm had
been included. If more than one paper presented data from the
same group of patients, we selected the most recent paper.
Nomenclature description
For the purpose of this study, pregnancy outcome
nomenclature was defined as follows: i) The pregnancy
was considered clinical if a gestational sac was visualized by
ultrasonography on the seventh week of gestation. The
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clinical pregnancy rate was the ratio between the number of
clinical pregnancies after embryo transfers and the number of
initiated ICSI cycles (per cycle) or number of embryo
transfers (per transfer). ii) Ectopic pregnancies were regis-
tered as clinical pregnancies occurring outside the uterine
cavity. iii) Spontaneous abortion was defined as pregnancy
loss anytime from the establishment of pregnancy to the
completion of 20 gestational weeks. The miscarriage rate was
the ratio of the number of spontaneous abortions and number
of clinical pregnancies. iv) Live birth included deliveries that
resulted in at least one live birth. The live birth rate was the
ratio between the number of live birth deliveries and the
number of initiated ICSI cycles (per cycle) or number of
embryo transfers (per transfer). v) Multiple births were
pregnancies resulting in more than one birth. vi) Preterm
births were those taking place after 20 but before 37
gestational weeks. vii) Low birth weight and very low birth
weight were defined as babies weighing less than 2,500 g and
1,500 g, respectively, at birth. viii) Perinatal mortality
included stillbirths after 20 weeks of gestation and neonatal
deaths (deaths within the first 28 days). ix) Birth defects were
defined as structural, functional or developmental abnorm-
alities presented at birth or later due to genetic or non-genetic
factors acting before birth.
& RESULTS
Study Group
A total of 1,092 ICSI cycles were performed in 835 patients.
Patient characteristics and a comparison of laboratory and
clinical ICSI outcomes are shown in Table 2. Groups were
homogeneous in terms of the mean age of the female
partners, female serum hormones, and the proportion of
females with an associated fertility problem. There were no
statistically significant differences in the numbers of
retrieved oocytes and transferred embryos to the uterine
cavity among the groups. The percentages of normal
fertilization and high-quality embryos available for transfer
were significantly lower in the group of men with NOA, but
they did not differ if sperm injections were performed using
non-ejaculated sperm from men with OA or ejaculated sperm
from patients with male infertility.
The rates of clinical pregnancy and live birth were lowest
in the NOA group. Live birth rates differed between the NOA
group (21.4%) compared with OA (37.5%) and ejaculated
sperm (32.3%; p= 0.003). Miscarriage, ectopic pregnancy and
multiple pregnancy rates did not differ among the groups.
Three hundred and twenty-six live births resulted from
1,041 fresh embryo transfers (live birth rate of 31.3%). The
distribution of live births in relation to parity, gestational
age, and birth weight is shown in Table 3. A total of 427
babies was delivered and assessed. Overall, differences
were not observed among groups for gestational age and
birth weight in the three parity stratifications. Similarly, the
rates of preterm birth, low birth weight and very low birth
weight did not differ among groups in the studied parity
stratifications. The preterm birth rates were greatest for
singletons in OA (17.9%) and for twins in both OA (47.1%)
and NOA (44.5%) compared with the ejaculated group
(9.7% and 27%, respectively), but these differences were not
significant (p= 0.15). We noted a tendency towards lower
gestational age for twins in the OA group (35.6¡2.8)
compared with the NOA (36.2¡2.4) and ejaculated groups
(37.0¡2.3), but the numbers were relatively small to reach
statistical significance (p= 0.06). The overall perinatal death
and malformation rates were 2.8% and 1.6%, respectively,
and the results did not differ among groups. The frequency
of babies of the male gender was higher in the OA group
(56.4%) compared with the NOA (41.4%) and ejaculated
(39.7%) groups (p= 0.02).
Systematic Review
We reviewed 373 abstracts relevant to ICSI, male infertility
and pregnancy. To address the key question discussed in this
Table 2 - Patient Characteristics and Comparison of Laboratory and Clinical Outcomes after Sperm Injections in
Azoospermic (Obstructive and Nonobstructive) and Non-azoospermic Infertile Males.
Obstructive Azoospermia Nonobstructive Azoospermia Ejaculated Sperm p-value
Patient Characteristics
No. of patients 182 188 465
Mean ¡ SD male age; years 42.6¡9.0a 37.0¡7.6b 36.3¡8.9c ,0.001(a vs. b,c)
Mean ¡ SD female age; years 32.6¡5.8 32.4¡4.7 33.0¡6.8 0.26
Laboratory Outcomes
No. of cycles 243 228 621
Mean ¡ SD no. oocytes retrieved 11.8¡7.7 12.7¡6.9 11.7¡7.0 0.07
Mean ¡ SD% 2PN fertilization* 62.9¡22.3a 43.7¡27.9b 64.5¡35.8c ,0.001(b vs. a,c)
Mean ¡ SD% high-quality embryo1 52.50¡30.2a 45.3¡33.6b 47.8¡32.4c = 0.01(b vs. a,c)
No. embryo transfers 237 210 594
Mean ¡ SD no. embryos transferred 2.7¡1.3 2.7¡1.6 2.7¡1.4 0.99
Clinical Outcomes
No. clinical pregnancies (%) 116 (48.9)a 60 (28.6)b 248 (41.7)c ,0.001(b vs. a,c)
No. ectopic pregnancies (%) 2 (1.7) 3 (5.0) 8 (3.2) 0.22
No. miscarriages (%) 24 (21.0) 11 (19.2) 47 (19.6) 0.75
No. live births (%) 89 (37.5)a 45 (21.4)b 192 (32.3)c = 0.003(b vs. a,c)
No. multiple births (%) 22 (24.4) 13 (28.3) 46 (23.8) 0.52
*PN = pronuclei (normal fertilization after sperm injections was defined as the presence of two pronuclei and a second polar body); 2PN fertilization rate
defined as the ratio of the number of normal 2PN fertilized oocytes and number of mature injected oocytes. 1Embryo quality was assessed according to
the arrangement and number of blastomeres, presence or absence of multinucleation, and degree of cytoplasmic fragmentation. Embryos were
considered high quality when 3-4 and 7-8 symmetrical blastomeres were seen on the second and third days of culture, respectively, with no
multinucleation and no more than 20% of the perivitelline space occupied with cytoplasmic fragments. The high-quality embryo rate is the ratio of the
number of high-quality embryos and number of embryos developed. Multiple births include live births resulting in more than one baby delivered. Each
live birth is considered a single event.
Reproductive potential of azoospermic males in ART
Esteves SC and Agarwal A
CLINICS 2013;68(S1):141-149
144
study, 20 manuscripts that directly compared pregnancy
outcomes between men with OA and NOA were included in
our analysis. Most studies were retrospective in nature.
Twelve studies provided data on pregnancy rates and/or live
birth only (Table 4). Four studies reported on neonatal
outcomes (Table 5). All studies were published in English.
Short-term pregnancy outcomes
We identified 12 studies that compared pregnancy out-
comes with ICSI using surgically-retrieved spermatozoa of
men with OA and NOA (Table 4). Six of these reported
decreased pregnancy rates (clinical or live birth) with sperm
from men with NOA compared with OA, and the other half
showed no difference in outcomes, regardless of the type of
azoospermia. A control group of sperm injections using
ejaculated sperm was available in six studies, and again,
conflicting results were noted. Three studies found lower
outcomes in the NOA group compared with either the OA
or ejaculated sperm groups, whereas three reported similar
pregnancy rates among the groups. One consistent finding
was that pregnancy outcomes did not differ if ejaculated
sperm or non-ejaculated sperm obtained from men with OA
were used for ICSI. Only three studies compared miscar-
riage rates; two reported no difference in risk of miscarriage
among the groups, whereas one showed a significant
increase in loss rates with ICSI using sperm from NOA
men. Ectopic pregnancy was occasionally reported but not
compared. None reported multiple pregnancy rates.
Long-term pregnancy outcomes
Four studies compared neonatal outcomes of children
born after ICSI using surgically-retrieved spermatozoa in
men with OA and NOA (Table 5). In general, the data
showed no major differences between children from fathers
with NOA and OA. Of note, lower gestational age in
singletons and increased frequency of premature twins
were reported in one study in the NOA group. Similar
congenital malformation rates, ranging from 1.3% to 5.2%
and 0% to 4.2%, were observed in the OA and NOA groups,
respectively. However, the data were based on a very
limited population. We did not identify any study compar-
ing long-term physical, neurological and developmental
outcomes in these categories of male infertility.
Expert Commentary
Currently, ICSI is widely used for patients with azoos-
permia, and several publications have reported the sperm
injection outcomes with non-ejaculated sperm. It has been
shown that neonatal outcomes, including karyotype results
and malformation rates, of children conceived with non-
ejaculated sperm are comparable to those of counterparts
conceived with the use of ejaculated sperm (35,36).
Bonduelle et al. and Jozwiak et al. analyzed karyotype
results of fetuses and newborns for which ejaculated and
testicular sperm were used for ICSI. Abnormal karyotypes
were found in 3.1% and 1.9% in the respective aforemen-
tioned studies when ICSI was performed with ejaculated
sperm, and those results did not differ from those obtained
by using testicular sperm (4.8% and 1.5%). However,
Bonduelle et al. called attention to the fact that the frequency
of de novo chromosomal anomalies was higher in the
testicular sperm group, but the numbers were too small to
allow definitive conclusions. Several investigators have also
studied congenital anomalies in such groups (37-40).
Ludwig et al. reported major malformation rates of 9.2%
Table 3 - Neonatal Outcomes of Children Born Following Sperm Injection in Azoospermic and Non-azoospermic Infertile
Males.
Obstructive
Azoospermia
Nonobstructive
Azoospermia Ejaculated Sperm p-value
No. live birth singletons 67 32 145
Mean ¡ SD gestational weeks at birth 37.5¡2.2 37.8¡2.1 38.0¡2.1 0.11
No. preterm births (%) 12 (17.9) 3 (9.4) 14 (9.7) 0.10
Mean ¡ SD birth weight (grams) 2,963¡480 2,957¡667 3,092¡579 0.24
No. low birth weights (%) 7 (10.5) 3 (9.4) 10 (6.9) 0.37
No. very low birth weights (%) 2 (2.9) 2 (6.2) 4 (2.8) 0.38
No. live birth twins 17 9 37
Mean ¡ SD gestational weeks at birth 35.6¡2.8 36.2¡2.4 37.0¡2.3 0.06
No. preterm births (%) 8 (47.1) 4 (44.5) 10 (27.0) 0.15
Mean ¡ SD birth weight (grams) 2,261¡594 2,357¡403 2,461¡672 0.30
No. low birth weights (%) 11 (64.7) 6 (66.6) 18 (48.7) 0.28
No. very low birth weights (%) 2 (11.7) 1 (11.1) 4 (10.8) 0.92
No. live birth triplets 5 4 9
Mean ¡ SD gestational weeks at birth 32.6¡3.1 32.3¡5.9 32.6¡4.5 0.93
No. preterm births (%) 4 (80.0) 2 (50.0) 2 (22.2) 0.37
Mean ¡ SD birth weight (grams) 1,660¡624 1,311¡471 1,600¡642 0.35
No. low birth weights (%) 4 (80.0) 3 (75.0) 8 (77.8) 0.87
No. very low birth weight (%) 2 (40.0) 3 (75.0) 3 (33.3) 0.32
Total No. children born 117 63 247
No. perinatal deaths* 3 (2.5) 4 (6.3) 5 (2.0) 0.10
Gender
No. boys (%) 66 (56.4)a 26 (41.4)b 98 (39.7)c 0.02 a vs. b,c
No. girls (%) 43 (36.8) 35 (55.5) 122 (49.4) 0.02 a vs. b,c
No. unknown (%) 8 (6.8) 2 (3.1) 27 (10.9) 0.06
No. birth defects (%) 2 (1.7) 2 (3.2) 3 (1.2) 0.26
*Perinatal deaths included stillbirths (birth of fetuses with no sign of life that occur after 20 weeks of gestation) and neonatal deaths (deaths within the
first 28 days). One stillbirth occurred in each group. Birth defects were defined as structural, functional or developmental abnormalities presented at
birth or later due to genetic or non-genetic factors acting before birth.
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and 3.8% in children born after the use of testicular and
epididymal spermatozoa, respectively; these values were
not significantly different than the rate of 8.4% with
ejaculated sperm (37). Other investigators reached similar
conclusions and reported even lower rates of congenital
anomalies in those groups (38-40). These publications,
however, failed to discriminate between the subgroups of
men with OA and NOA.
Nonetheless, few studies to date have addressed out-
comes by making a systematic distinction between OA and
NOA. This prevents consideration regarding the severity of
spermatic defects on ICSI results. Whereas men with OA
have normal sperm production, those with NOA have
severely defective spermatogenesis and a very limited
amount of sperm within the testes, if any, which may result
in an increased risk of genetic and epigenetic defects (41).
In this study, we compared the reproductive potential of
azoospermic men undergoing sperm injections according to
the type of azoospermia. A subgroup of non-azoospermic
infertile men treated with ICSI was included for comparison.
We noted that sperm injections with testicular sperm of men
with NOA resulted in lower fertilization and embryo
development compared with either the sperm of OA
individuals or ejaculated sperm of non-azoospermic men.
Moreover, clinical pregnancy and live birth rates were lowest
in the NOA group, whereas no difference was observed
between the groups of OA and ejaculated sperm. We also
reported the neonatal profile of babies born with ICSI and
showed similar outcomes from using NOA, OA or ejaculated
sperm. Although we noted that the preterm birth rates were
greatest for singletons from OA and twins from both OA and
NOA and that the gestational age was lowest for twins from
OA, our data involved a limited population. In our series,
congenital malformation (1.6%) and perinatal death rates
(2.8%) did not differ between groups and are in agreement
with those reported in larger cohorts (32-34). Given the
relative rarity of specific birth defects, identifying an
association between a specific exposure and subsequent risk
is difficult. Moreover, not all major malformations are found
at birth, and a proportion of children were lost to follow-up
Table 4 - Studies Comparing Pregnancy Outcomes after Intracytoplasmic Sperm Injection using Surgically-retrieved
Spermatozoa in Men with Obstructive and Nonobstructed Azoospermia.
Authors; Year
(reference) Design Region
OA vs. NOA;
number of
cycles
Control group of
ejaculated sperm;
yes/no; No. cycles
Most relevant
pregnancy
outcome
assessed Main findings Other findings
Aboulghar et
al.; 1997 (21)
Retrospective Egypt 126 vs. 80 Yes; 102 CPR Lower CPR for NOA
compared with
other groups
Miscarriage rate and
multiparity rates presented
but not compared
Ghazzawi et al.
1998 (22)
Prospective Jordan 19 vs. 30 Yes; 28 LBR Lower LBR when
testicular sperm from
men with NOA was used
(10%) compared with
ejaculated (21%) or
epididymis (22%)
Increased miscarriage rate
when testicular sperm from
NOA men were used
Ubaldi et al.;
1999 (23)
Prospective
controlled
Italy 33 vs. 29 Yes; 62 Ongoing
pregnancy and
LBR
Similar results
among groups
Implantation rate lower in
NOA (13.4%) vs. ejaculated
sperm or OA (,26%)
Palermo et al.;
1999 (24)
Retrospective USA 255 vs. 53 No LBR Lower LBR with testicular
sperm from NOA vs.
epididymal sperm from
OA
Similar malformation
rate between groups
De Croo et al.;
2000 (25)
Retrospective Belgium 139 vs. 54 No LBR Similar LBR between OA
(16.2%) and NOA (22.6%)
Miscarriage and
multiparity described
but not compared
Bukulmez et
al.; 2001 (26)
Retrospective Turkey 43 vs. 53 Yes; 780 CPR No difference in outcome NR
Schwarzer et
al. 2003 (27)
Retrospective Germany 300 vs. 414 No LBR Lower LBR in NOA
(19%) vs. OA (28%)
NR
Ghanem et al.;
2005 (28)
Case series and
meta-analysis of
cohort studies
Egypt 48 vs. 42 No CPR Similar CPR between
OA (25%) and
NOA (23.1%)
Lower fertilization
rate in NOA
La Sala et al.;
2006 (29)
Retrospective Italy NA NA CPR Similar CPR in OA
(12.9%) vs. NOA (15.4%)
NR
Verza Jr &
Esteves;
2008 (15)
Retrospective Brazil 39 vs. 54 Yes; 220 CPR Lower pregnancy
rates (25.9%) in NOA
compared with OA
(51.3%) and ejaculated
sperm (36.6%)
Miscarriage rates did not
differ between groups
Semia˜o-
Francisco et
al.; 2010 (30)
Retrospective Brazil 274 vs. 102 No CPR No differences in
CPR between groups
Higher miscarriage rate
in OA with the use of
testicular sperm compared
with epididymal sperm
He et al.,
2010 (31)
Retrospective China 112 vs. 42 No CPR Lower CPR in NOA
(21.4%) than OA (40.2%)
Similar miscarriage rates
AO = obstructive azoospermia; NOA = nonobstructive azoospermia; LBR = live birth rate; CPR = clinical pregnancy rate; NR = not reported; NA = not
available.
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(Table 3). It is therefore possible that the number of
malformations is underestimated.
We also presented a systematic review of published data
comparing the pregnancy outcomes following ICSI for the
treatment of male infertility due to obstructive and
nonobstructive azoospermia and the short- and long-term
safety of such interventions. We noted that few studies have
specifically compared sperm injection outcomes taking into
account the type of azoospermia. Moreover, these studies
had several shortcomings. The majority were retrospective
case studies that only provided data on pregnancy rates
(clinical or live birth). We were unable to identify follow-up
studies on the physical, neurological, and developmental
outcomes of children from fathers with these categories of
male infertility. In general, the clinical pregnancy and live
birth rates reported in the literature range from 26-57% and
18-55% in NOA and OA, respectively, and the results are
similar to those reported with ICSI using ejaculated sperm
(15,21-31). Although the assessment of fertilization and
implantation rates was not the scope of this study, we noted
that such parameters were lower with ICSI using testicular
spermatozoa of men with NOA compared with ejaculated
sperm or epididymal/testicular sperm of men with OA
(15,23). Nonetheless, conflicting reports exist regarding
whether clinical pregnancy and live birth rates are affected
by the type of azoospermia. Studies have reported either a
decrease (15,21,22,24,27,31) or no difference (23,25,26,28-30)
in pregnancy outcomes with ICSI in cases of NOA and OA,
respectively. Such decreased reproductive potential of men
with NOA seen in some studies may be explained by the
fact that testicular spermatozoa from men with severely
impaired spermatogenesis have a higher tendency to carry
deficiencies, such as the those related to the centrioles and
genetic material, which ultimately affect the capability of the
male gamete to activate the egg and trigger the formation
and development of a normal zygote and viable embryo
(32).
Palermo et al. (1999), Vernaeve et al. (2003), and Belva et
al. (2011) were among the few researchers that differentiated
between men with OA and NOA. In the first study, the
frequency of congenital malformation did not differ in
relation to the sperm source or type of azoospermia. In the
study of Vernaeve et al., malformation rates of 4% and 3%
were reported after the use of testicular sperm of NOA and
OA patients, respectively. Recently, Belva et al. reported on
the neonatal outcome of 724 children born after ICSI using
non-ejaculated sperm and included a subgroup analysis of
the type of azoospermia in which the frequencies of major
malformation and karyotype anomalies were not different
in OA and NOA.
Despite the limited population analyzed, some differ-
ences observed in our study and that of Vernaeve et al. (32)
regarding the gestational age and birth weight of babies
born call for continuing monitoring. Because intrauterine
growth is strongly dependent on placental function, these
observations may suggest increased abnormalities of
implantation/placentation in such pregnancies. The extent
to which this is a function of treatment, maternal/
embryonic factors, or both is yet to be determined.
This report has several limitations, including the restric-
tion of studies to English, Portuguese and Spanish
languages, the potential for missing relevant studies, and
the lack of studies with large patient samples and meta-
analysis. As noted, the relative lack of data on fetal, neonatal
and long-term outcomes in the studied male infertility
categories should be identified as a major research priority.
As such, future research considerations should include the
use of multi-center trials with adequate sample sizes, the
development of standard data sets to differentiate between
the groups of men with OA and NOA, and control groups of
children conceived with ICSI using ejaculated sperm to
facilitate meta-analyses and reach a consensus on significant
clinical differences to aid sample size estimates, especially
for less common outcomes.
Key issues
N In our series of 1,092 ICSI cycles performed in 835 male
infertility patients, live birth rates were lowest in the
Table 5 - Studies Comparing Neonatal and Developmental Outcomes of Children Born Following Intracytoplasmic
Sperm Injection using Surgically-retrieved Spermatozoa from Men with Obstructive and Nonobstructed Azoospermia.
Authors; Year
(reference) Design Region
OA vs. NOA;
Number of
children
Control group of
children born with
ejaculated sperm;
yes/no Outcomes assessed Main findings
Palermo et al.
1999 (24)
Retrospective USA 158 vs. 22 No Malformation rate Congenital malformation rate
did not differ in OA (1.3%)
compared with NOA (4.5%)
Vernaeve et al.
2003 (32)
Retrospective Belgium 196 vs. 61 No Multiple pregnancy
rates, gestational
age, birth weight,
preterm delivery,
low birth weight,
malformation rate
Similar multiple birth, overall preterm
delivery, low birth weight, perinatal
death and malformation rates (3%
OA; 4% NOA). Lower gestational age
in singletons and increased frequency
of premature twins in the NOA group
Fedder et al
2007 (33)
Retrospective Denmark 282 vs. 76 No Multiple pregnancy
rates; congenital
anomalies
Malformation rate in OA (4.0%); No
malformations reported in NOA
group
Belva et al.;
2011 (34)
Prospective Belgium 474 vs. 193 No Multiple pregnancy
rates, gestational age,
birth weight, preterm
delivery, low birth
weight, malformation rate
Similar multiple birth, overall
preterm delivery, low birth weight,
perinatal death and malformation
rates (5.2% OA; 4.2% NOA)
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NOA group. Miscarriage, ectopic pregnancy and multi-
ple pregnancy rates were not different between clinical
pregnancies obtained using ejaculated or non-ejaculated
sperm from men with OA or NOA.
N Of the 427 babies born following ICSI using sperm from
non-azoospermic infertile fathers and azoospermic
fathers with OA and NOA, the short-term neonatal
outcomes were similar among groups, despite a
tendency towards higher preterm births in both azoos-
permia categories and lower gestational age for twins
from OA. The overall perinatal death and malformation
rates were 2.8% and 1.6%, respectively, and our results
did not differ regarding whether deliveries following
ICSI used ejaculated or non-ejaculated sperm from men
with OA or NOA.
N Most published studies that addressed pregnancy and
neonatal outcome of children born after the use of non-
ejaculated sperm suffer from methodological shortcom-
ings. The population included is small, and in general,
no discrimination is made between OA and NOA.
N To date, few studies have directly compared pregnancy
outcomes between OA and NOA, and the data are
limited. Most of the studies were not designed to detect
differences in pregnancy and live birth rates and had
low power to detect differences in less-frequent out-
comes, such as multiple births and complications.
N In general, clinical pregnancy and live birth rates
reported in the literature range from 26-57% for NOA
and 18-55% for OA, and the results are similar to those
reported with ICSI using ejaculated sperm. Published
studies have shown either a decrease or no difference in
pregnancy outcomes with ICSI in cases of NOA and OA.
No major difference was noted in short-term neonatal
outcomes and congenital malformation rates between
children from fathers with NOA and OA. However,
these results are based on a very limited population, and
tendencies towards lower gestational age and birth
weight of babies born from azoospermic fathers call for
continued monitoring.
N No follow-up study has yet compared the long-term
physical, neurological and developmental outcomes of
children born with ICSI using sperm from azoospermic
men with OA and NOA.
N Due to the relative lack of data on fetal, neonatal and
long-term outcomes of children born from azoospermic
fathers, future studies should include the use of multi-
center trials with adequate sample size and development
of standard datasets to differentiate between the groups
of men with OA and NOA. Efforts should also be made
to reach a consensus on significant clinical differences
regarding sample size estimates, especially for less
common outcomes, thus facilitating meta-analyses.
N Currently, the limited evidence regarding pregnancy
and postnatal outcomes of ICSI using surgically-derived
sperm from azoospermic men is reassuring, but a call for
continuous monitoring is of utmost importance to
support the recommendation of sperm retrieval and
ICSI in such male infertility categories.
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